Dr. Θεοδώρα Γιολτζόγλου Ειδικός Νευρολόγος Θεσσαλονίκη

Αφορά στην νόσο Πάρκινσον και τις διαταραχές κινητικότητας

1. Βασική έρευνα:

Διδακτορική διατριβή με θέμα «Ο ρόλος της αστρογλοίας στη διαδικασία νευροεκφύλισης σε πειραματικό μοντέλο της νόσου του Πάρκινσον», από την οποία προέκυψαν οι παρακάτω εργασίες:

1. “Pole test and dopaminergic cell loss correspondence in two different MPTP mouse models” (Gioltzoglou T, Lourbopoulos A, Nousiopoulou E, Touloumi O, Milonas I, Taskos N, Grigoriadis N), 13^th International Congress of Parkinson’s Disease and Movement Disorders, 7-11 June 2009, Paris.
2. “Kinetics of astroglial response in relation to neurodegeneration in two different MPTP models” (Gioltzoglou T, Lourbopoulos A, Nousiopoulou E, Touloumi O, Milonas I, Taskos N, Grigoriadis N), 24^th Panhellenic Congress of Neurology, 20-23/5/2010, Kos.
3. “Pole test and dopaminergic cell loss correspondence in two different MPTP mouse models” (Gioltzoglou T, Lourbopoulos A, Nousiopoulou E, Touloumi O, Milonas I, Taskos N, Grigoriadis N), 24^th Panhellenic Congress of Neurology, 20-23/5/2010, Kos.
4. “Nestin protein is expressed in striatal astrocytes in the acute though not the chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model” (Theodora Gioltzoglou, Athanasios Lourbopoulos, Evangelia Nousiopoulou, Eleni Polyzoidou, Olga Touloumi, Ioannis Milonas, Nikolaos Taskos, Nikolaos Grigoriadis), 14^th International Congress of Parkinson’s Disease and Movement Disorders, 13-17 June 2010, Buenos Aires.
5. “Evidence for NFkB – related neuronal and glial pathology in the acute though not the chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model” (Theodora Gioltzoglou, Athanasios Lourbopoulos, Evangelia Nousiopoulou, Eleni Polyzoidou, Olga Touloumi, Ioannis Milonas, Nikolaos Taskos, Nikolaos Grigoriadis), 14^th Congress of the European Federation of Neurological Societies, 25-18 September 2010, Geneva.

Επίσης από το 2007, είμαι μέλος της ομάδας των reviewers του περιοδικού “Neural Regeneration Research”.

Πολυκεντρικές μελέτες για νέα φάρμακα στην νόσο Πάρκινσον:

1. DA2APD-0075-031
2. STRIDE PD (CELC200A2401/2939107)
3. TRUST

1. 2000/2001: Πρόγραμμα άσκησης στην Πυρηνική Ιατρική για γιατρούς (25 μαθήματα).
2. 23/11-27/11/2004: Μεταπτυχιακό σεμινάριο νευροανοσολογίας (22 ώρες).
3. 10/2-11/2/2005: Deep Brain Stimulation for the Treatment of Parkinson Disease and Essential Tremor Training Barcelona, Spain.
4. 19/5- 21/5/2006: Myofascial Pain and Dysfunction – Trigger Points, Thessaloniki

1. Gioltzoglou T, Cordivary C, Lee PJ, Hanna MG, Lees AJ. Problems with botulinum toxin treatment in mitochondrial cytopathy: a case report and review of the literature. Journal of Neurology, Neurosurgery, and Psychiatry 2005; 76:1594-1596.

2. Gioltzoglou T, Milonas I, Lees AJ. Case of DYT1 dystonia triggered by bite from a moray. Mov Disord. 2006 Sep;21(9):1536-7.

3. ‘Epidemiology, aetiology and pathogenesis of Parkinson’s disease’ – “Prosengisis” 1995, March, 30 : 38 – 43.

4. G..Mentenopoulos, T. Doskas, T. Gioltzoglou, M. Soumpourou, T. Afrantou,P.Ιoannides, I. Milonas. Pramipexole in the treatment of restless legs syndrome : a follow up study. European Journal of Neurology, p. 208, vol. 9 suppl 2, October 2002.

5. Orologas A,Gioltzoglou T, Pervanidou D, Soumpourou M, Afrantou T, Ntoskas T. Multiple Sclerosis and Guilain Barre Syndrome: a case report. Neurologia 11: 3-2002.

6. Karakostas D, Afrantou T, Gioltzoglou T, Chatzisotiriou A, Patsalas I, Kontopoulos B, Drevelengas A, Kouskouras K, Milonas I. Solitary metastasis of lung adenocarcinoma in the III ventricle. Neurologia 11: 3-2002.

7. Gioltzoglou T, Mavromatis I, Pervanidou D, Koutoula O, Balla C, Milonas I. Multifocal acquired demyelinating sensory and motor neuropathy: a case report responsive to IVIG treatment. Journal of Neurology, Vol 252, Suppl 2, June 2005.

8. Papadopoulos K, Gioltzoglou T, Triantafillou A, Milonas I. Amyatrophic choreoathetosis with acanthocytosis: a case report. Journal of Neurology, Vol 252, Suppl 2, June 2005.

9. Gioltzoglou T, Orologas A. Primary progressive multiple sclerosis (PPMS) presenting as fatigue and depression: a case report. European Journal of Neurology, p. 132, vol. 12 suppl 2, September 2005.

10. Gioltzoglou T, Milonas I. Hedonistic Homeostatic Dysregulation Syndrome: a report of two cases. European Journal of Neurology, p. 79, vol. 13 suppl 2, September 2006.

11. Kanta O, Gioltzoglou T, Taskos N, Milonas I. Paroxysmal Dyskinesia as a Presenting Symtom of Multiple Sclerosis. European Journal of Neurology, p.240, vol. 13 suppl 2, September 2006.

12. Balla c, Gioltzoglou T, Artemis N, Taskos N. Progressive supranuclear palsy with hyposmia and assymetric onset : a case report. European Journal of Neurology, p 101, vol 15, September 2008.

13. Gioltzoglou T, Lourbopoulos A, Nousiopoulou E, Touloumi O, Milonas I, Taskos N, Grigoriadis N. Pole test and dopaminergic cell loss correspondence in two different MPTP mouse models. Movement Disorders, S33-34, vol 24, May 2009.

14. “Nestin protein is expressed in striatal astrocytes in the acute though not the chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model” (Theodora Gioltzoglou, Athanasios Lourbopoulos, Evangelia Nousiopoulou, Eleni Polyzoidou, Olga Touloumi, Ioannis Milonas, Nikolaos Taskos, Nikolaos Grigoriadis), Movement Disorders, S206, vol 25(S2), May 2010.

15. “Evidence for NFκB –related neuronal and glial pathology in the acute though not the chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model” (Theodora Gioltzoglou, Athanasios Lourbopoulos, Evangelia Nousiopoulou, Eleni Polyzoidou, Olga Touloumi, Ioannis Milonas, Nikolaos Taskos, Nikolaos Grigoriadis), European Journal of Neurology, p 116, vol 17, September 2010.

1. Διάγνωση της νόσου του Πάρκινσον. Στο : Μεντενόπυλος Γ., Μπούρας K., Η νόσος του Πάρκινσον. University Studio Press, Thessaloniki, 2008.

1. “Dystonic Disorders” In: 2^nd Department of Neurology, AHEPA hospital, Postgraduate Seminars and Lectures, Fall 2005.
2. “ Musician’s Dystonia as a part of the Dystonic Spectrum” In: 1^st World Congress “Musicians’ Medicine”, 7-9/4/2006, Thessaloniki
3. “ New Developments in the Treatment of Parkinson’s Disease” In: “Alzheimer’s Disease – Parkinson’s Disease” Meeting of the Greek Neurologic Society, 23/9 2006, Istanbul.
4. “Diagnosis of Parkinson’s Disease” in 2^nd Congress of IKA, June 2007.
5. “Etiopathogenesis of Parkinson’s Disease” Part of Round Table in 22^nd

Congress of Greek Neurologists, 1-5/May 2008, Chania.

1. “Presentation of video case” in Movement Disorders Teaching Course, in 23^rd Congress of Greek Neurologists,14-17 May 2009, Thessaloniki.
2. “Neuroimmunology of Movement Disorders” in Neuroimaging in Nuclear Medicine, 20/3/2010, Thessaloniki.
3. Psychiatric Complications of dopa-treatment. Part of Round table in 3^rd European Congress of the International Neuropsychiatric Association and 4^th Mediterranean Congress of the World Federation of Societies of Biological Psychiatry, 18-21 November 2010, Thessaloniki.
4. "The pharmacology in Parkinson's disease" Στρογγυλή τράπεζα στο 5th International Congress on Brain and Behaviour and 18th Thessaloniki Conference, 3-6 November 2011, Thessaloniki και 10. Latest pharmacological approach in Parkinson's disease. Στρογγυλή τράπεζα στο Joint WPA-INA-HSRPS International Psychiatric Congress, 29/11-2/12-2012, Athens

1. “Depression in institutionalized patients”, (D. Kalfas, I. Pavlidis, Th. Gioltzoglou, I. Pervos, A. Chatzidimou, A. Papanikolaou, A. Kanistras), in the 13th South European Society for Neurology and Psychiatry Congress, 27-30/9/2000, Thessaloniki.
2. “Pramipexole in depression in Parkinson’s disease”,(G. Mentenopoulos, T. Doskas, T. Gioltzoglou, M. Suburu, I. Milonas), XII World Congress of Psychiatry, Yokohama, Japan.
3. “Pramipexole in the treatment of restless legs syndrome : a follow up study”, (G. Mentenopoulos, T. Doskas, T. Gioltzoglou, M. Soumpourou, T. Afrantou, P. Ioannides, I. Milonas), 6^th Congress of the EFNS (European Federation of Neurological Societies), 26-29/10/2002, Vienna.
4. “Multiple Sclerosis and Guilain Barre Syndrome: a case report”, (Orologas A, Gioltzoglou T, Pervanidou D, Soumpourou M, Afrantou T, Ntoskas T.), 18^th Panhellenic Congress of Neurology, 6-9/11/2002, Athens.
5. “Solitary metastasis of lung adenocarcinoma in the III ventricle”, (Karakostas D, Afrantou T, Gioltzoglou T, Chatzisotiriou A, Patsalas I, Kontopoulos B, Drevelengas A, Kouskouras K, Milonas I.), 18^th Panhellenic Congress of Neurology, 6-9/11/2002, Athens.
6. “The efficacy of Quetiapine in Parkinsonian- Demented patients” (Doskas T., Soumpourou M., Gioltzoglou T., Afrantou T., Milonas I.), 14^th Conference of the South – East European Society for Neurology and Psychiatry, 16 – 19/10/2003, Thessaloniki.
7. “Dysgenesis of corpus callosum, heterotopia of gray matter and intrahemispheric cyst in a young adult” (Tsounis S., Afrantou T., Triantafillou A., Gioltzoglou T., Milonas I), 14^th Conference of the South – East European Society for Neurology and Psychiatry, 16 – 19/10/2003, Thessaloniki.
8. “Multifocal acquired demyelinating sensory and motor neuropathy: a case report responsive to IVIG treatment” (Giltzoglou T, Mavromatis I, Pervanidou D, Koutoula O, Balla C, Milonas I), 15^th Meeting of the European Neurological Society, 18 – 22/6/2005, Vienna.
9. “Amyatrophic choreoathetosis with acanthocytosis: a case report” (Papadopoulos K, Gioltzoglou T, Triantafillou A, Milonas I), 15^th Meeting of the European Neurological Society, 18 – 22/6/2005, Vienna.
10. “Primary progressive multiple sclerosis (PPMS) presenting as fatigue and depression: a case report”, (Gioltzoglou T, Orologas A), 9^th Congress of the EFNS (European Federation of Neurological Societies), 17 – 20/9/2005, Athens.
11. “Hedonistic Homeostatic Dysregulation Syndrome: a report of two cases” (Gioltzoglou T, Milonas I.). 10^th Congress of the EFNS (European Federation of Neurological Societies), 2-5/9/2006, Glasgow.
12. “Paroxysmal Dyskinesia as a Presenting Symptom of Multiple Sclerosis” (Kanta O, Gioltzoglou T, Taskos N, Milonas I). 10^th Congress of the EFNS (European Federation of Neurological Societies), 2-5/9/2006, Glasgow.
13. “Surgical treatment of a cortical malformation in a medically resistant epilepsia partialis continua” (Koutoula O, Karacostas D, Foroglou N, Karkavelas G, Taskos N, Gioltzoglou T, Milonas I), 2^nd Panhellenic Congress of Epilepsy, 10 – 12/11 2006, Thessaloniki.
14. “Pole test and dopaminergic cell loss correspondence in two different MPTP mouse models” (Gioltzoglou T, Lourbopoulos A, Nousiopoulou E, Touloumi O, Milonas I, Taskos N, Grigoriadis N), 13^th International Congress of Parkinson’s Disease and Movement Disorders, 7-11 June 2009, Paris.
15. “Kinetics of astroglial response in relation to neurodegeneration in two different MPTP models” (Gioltzoglou T, Lourbopoulos A, Nousiopoulou E, Touloumi O, Milonas I, Taskos N, Grigoriadis N), 24^th Panhellenic Congress of Neurology, 20-23/5/2010, Kos.
16. “Pole test and dopaminergic cell loss correspondence in two different MPTP mouse models” (Gioltzoglou T, Lourbopoulos A, Nousiopoulou E, Touloumi O, Milonas I, Taskos N, Grigoriadis N), 24^th Panhellenic Congress of Neurology, 20-23/5/2010, Kos.
17. “Nestin protein is expressed in striatal astrocytes in the acute though not the chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model” (Theodora Gioltzoglou, Athanasios Lourbopoulos, Evangelia Nousiopoulou, Eleni Polyzoidou, Olga Touloumi, Ioannis Milonas, Nikolaos Taskos, Nikolaos Grigoriadis), 14^th International Congress of Parkinson’s Disease and Movement Disorders, 13-17 June 2010, Buenos Aires.
18. “Evidence for NFκB –related neuronal and glial pathology in the acute though not the chronic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model” (Theodora Gioltzoglou, Athanasios Lourbopoulos, Evangelia Nousiopoulou, Eleni Polyzoidou, Olga Touloumi, Ioannis Milonas, Nikolaos Taskos, Nikolaos Grigoriadis), 14^th Congress of the EFNS (European Federation of Neurological Societies), 25-28 September 2010, Geneva.

1. 2^nd Congress of the Surgical Union of North Greece 12-14/10/1995, Thessaloniki.
2. Hand Surgery meeting, 29/1/2000, Xanthi.
3. 1^st Panhellenic Congress “Sports Medicine in 21^st century”, 10-12/5/2001, Thessaloniki.
4. “Diurnal Somnolence : causes and consequences”- meeting, 10/3/2001, Thessaloniki.
5. 19^th Spring Meeting of Greek Neurologists, 18-20/5/2001, Kalambaka.
6. XVII World Congress of Neurology, 16-22 June 2001, London.
7. “The autoimmune diseases for non specialists”, meeting, 8/12/2001, Thessaloniki.
8. “Neurologic Emergencies in paediatric practice”, meeting, 30/3/2002, Thessaloniki.
9. “Epilepsy, diagnosis and treatment”, meeting, 6/4/2002, Thessaloniki.
10. 6^th EFNS Congress, 26-29 October 2002, Vienna.
11. 7^th EFNS Congress, 30/8-2/9 2003, Helsinki.
12. 14^th Conference of the South – East European Society for Neurology and Psychiatry, 16 – 19/10/2003, Thessaloniki
13. 1^st Educational Meeting of the Greek Neurologic Society about “Spasticity”, 14/12/2003, Thessaloniki( 1 CME credit)
14. 14^th Meeting of the European Neurological Society, 26 – 30/6 2004, Barcelona.
15. 19^th Panhellenic Congress of Neurology, 17 – 20/3/2005, Thessaloniki (7 CME credits).
16. 9^th EFNS Congress, 17-20/9 2005, Athens.
17. 20^th Panhellenic Congress of Neurology, 16 – 19/3/2006, Larissa (5 CME credits).
18. 1^st World Congress “Musicians’ Medicine”, 7-9/4/2006, Thessaloniki.
19. 10^th EFNS Congres, 2 – 5/9 2006, Glasgow (4 CME credits).
20. “Alzheimer’s Disease – Parkinson’s Disease” Meeting of the Greek Neurologic Society, 23/9 2006, Istanbul (3 CME credits).
21. 15^th Conference of the South – East European Society for Neurology and Psychiatry, 11 – 14/10 2006, Thessalonki.
22. 2^nd Panhellenic Congress of Epilepsy, 10 – 12/11 2006, Thessaloniki.
23. Congress on “Child Immobility” 17 – 18/3 2007, Thessaloniki (9 CME credits).
24. 21^st Panhellenic Congress of Neurology, 19 – 22/4/2007, Athens (21 CME credits).
25. 11^TH International Congress of Parkinson’s Disease and Movement Disorders, 3-7 June 2007, Istanbul (37 CME credits).
26. 14^th Meeting of the European Neurological Society, 16 – 20/6/2007, Rhodes (15 CME credits).
27. 11^th EFNS Congress, 24 – 28/8/2007, Brussels.
28. 3^rd International Congress on Brain and Behavior, 28/11 – 2/12/07, Thessaloniki.
29. 22^nd Panhellenic Congress of Neurology, 1-5/5/08, Chania ( credits)
30. Toxins 2008, 12-14/6/08, Baveno, Italy
31. 12^th EFNS Congress, 23-26/8/2008, Madrid.
32. Activa DBS CCGI-Advanced users meeting, 23-24/2/09, Athens.
33. 9^th International Conference AD/PD 2009, 11-15/3/09, Prague (25 credits).
34. 23^rd Congress of Greek Neurologists,14-17 May 2009, Thessaloniki.
35. 13^th International Congress of Parkinson’s Disease and Movement Disorders, 7-11 June 2009, Paris.
36. 24^th Panhellenic Congress of Neurology, 20-23/5/2010, Kos.
37. 14th Congress of the EFNS (European Federation of Neurological Societies), 25-28 September 2010, Geneva.
38. 14^th International Congress of Parkinson’s Disease and Movement Disorders, 13-17 June 2010, Buenos Aires.
39. 3^rd European Congress of the International Neuropsychiatric Association and 4^th Mediterranean Congress of the World Federation of Societies of Biological Psychiatry, 18-21 November 2010, Thessaloniki.
40. 7^th International Congress on Mental Dysfunctions and other Non-Motor Features in Parkinson’s Disease and Related Disorders, 9-12 December 2010, Barcelona.
41. “Neurophysiology, Diagnosis and Therapy in Neurology (MS and Movement Disorders)”, 20-21 May 2011, Corfu.
42. 15^th International Congress of Parkinson’s Disease and Movement Disorders, 13-17 June 2011, Toronto, ON, Canada.